Free Trial
NYSE:INFU

InfuSystem (INFU) Stock Price, News & Analysis

InfuSystem logo
$5.95 -0.06 (-1.00%)
As of 10:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About InfuSystem Stock (NYSE:INFU)

Key Stats

Today's Range
$5.93
$6.00
50-Day Range
$5.19
$6.46
52-Week Range
$4.61
$9.97
Volume
20,621 shs
Average Volume
152,569 shs
Market Capitalization
$125.05 million
P/E Ratio
99.02
Dividend Yield
N/A
Price Target
$12.50
Consensus Rating
Strong Buy

Company Overview

InfuSystem Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

INFU MarketRank™: 

InfuSystem scored higher than 68% of companies evaluated by MarketBeat, and ranked 360th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InfuSystem is 100.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.32.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InfuSystem is 100.18, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.39.

  • Price to Book Value per Share Ratio

    InfuSystem has a P/B Ratio of 2.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.83% of the float of InfuSystem has been sold short.
  • Short Interest Ratio / Days to Cover

    InfuSystem has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InfuSystem has recently decreased by 73.93%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InfuSystem does not currently pay a dividend.

  • Dividend Growth

    InfuSystem does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.83% of the float of InfuSystem has been sold short.
  • Short Interest Ratio / Days to Cover

    InfuSystem has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InfuSystem has recently decreased by 73.93%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    InfuSystem has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.08 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for InfuSystem this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for INFU on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $46,629.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    11.40% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InfuSystem's insider trading history.
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Stock News Headlines

Roth Capital Predicts InfuSystem's Q2 Earnings (NYSE:INFU)
InfuSystem (NYSE:INFU) Now Covered by Analysts at Roth Capital
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
InfuSystem: Investments Are Starting To Pay Off
See More Headlines

INFU Stock Analysis - Frequently Asked Questions

InfuSystem's stock was trading at $8.45 at the start of the year. Since then, INFU shares have decreased by 28.9% and is now trading at $6.01.

InfuSystem Holdings, Inc. (NYSE:INFU) posted its quarterly earnings data on Thursday, November, 7th. The company reported $0.08 EPS for the quarter, meeting analysts' consensus estimates of $0.08. The business had revenue of $35.32 million for the quarter, compared to analysts' expectations of $35.50 million. InfuSystem had a net margin of 1.12% and a trailing twelve-month return on equity of 2.78%.

Top institutional shareholders of InfuSystem include Williams & Novak LLC (0.06%) and CWM LLC (0.02%). Insiders that own company stock include Richard Dilorio, Carrie Lachance, Christopher R Sansone, Barry G Steele, Paul Andrew Gendron, R Rimmy Malhotra, Addam Chupa, Ralph F Boyd Jr, Kenneth D Eichenbaum, Kevin Whitman and Gregg Owen Lehman.
View institutional ownership trends
.

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/07/2024
Today
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:INFU
Previous Symbol
NYSE:INFU
CIK
1337013
Employees
410
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$12.00
Potential Upside/Downside
+110.1%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.14
Trailing P/E Ratio
99.02
Forward P/E Ratio
39.67
P/E Growth
N/A
Net Income
$870 thousand
Net Margins
1.12%
Pretax Margin
2.65%
Return on Equity
2.78%
Return on Assets
1.41%

Debt

Debt-to-Equity Ratio
0.50
Current Ratio
1.98
Quick Ratio
1.59

Sales & Book Value

Annual Sales
$137.58 million
Price / Sales
0.91
Cash Flow
$0.47 per share
Price / Cash Flow
12.79
Book Value
$2.47 per share
Price / Book
2.41

Miscellaneous

Outstanding Shares
21,016,000
Free Float
19,095,000
Market Cap
$125.05 million
Optionable
Optionable
Beta
1.81
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:INFU) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners